Introduction
• The prescription patterns of drugs for the treatment of attention-deficit/hyperactivity disorders (anti-ADHD drugs) in Japanese children and adolescents have not been fully investigated.
Objectives
• To examine anti-ADHD drug prescription patterns in Japanese children and adolescents.
Methods
• We conducted a cross-sectional survey during October 2013 on outpatients, aged 19 years or less, in 34 private mental clinics. Patients who were prescribed at least one antidepressant were analyzed in this report. Data were extracted on gender, age, principal psychiatric diagnosis (based on ICD-10), and types and doses of psychotropic drugs.
Discussion
• The results of this study indicated that nearly one-sixth of outpatients with ADHD in Japan received OROS-MPH/ATMX combination therapy. The use of OROS-MPH/ATMX combination therapy tended to increase as the treatment periods lengthened.
• Co-prescription of antipsychotics with anti-ADHD drugs was relatively popular in patients treated for three years or more. Table 3 . Anti-ADHD drug polypharmacy Table 2 . Anti-ADHD drug use in the study samples 
Results

